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Edited by Frances ShannonAbstract Histone acetyltransferases (HATs) regulate tran-
scription, chromatin structure and DNA repair. Here, we utilized
a novel HAT inhibitor, anacardic acid, to examine the role of
HATs in the DNA damage response. Anacardic acid inhibits
the Tip60 HAT in vitro, and blocks the Tip60-dependent activa-
tion of the ATM and DNA–PKcs protein kinases by DNA dam-
age in vivo. Further, anacardic acid sensitizes human tumor cells
to the cytotoxic eﬀects of ionizing radiation. These results dem-
onstrate a central role for HATs such as Tip60 in regulating the
DNA damage response. HAT inhibitors provide a novel thera-
peutic approach for increasing the sensitivity of tumors to radi-
ation therapy.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The acetylation of proteins is a dynamic event involving
acetylation by histone acetyltransferases (HATs) [1,2] and
deacetylation by histone deacetylases (HDACs) [3]. HATs pri-
marily acetylate the N-terminus of histones, and this acetyla-
tion is associated with transcriptionally activate chromatin
[4]. These acetylated lysine residues can function as docking
sites for bromodomains, protein domains which bind acety-
lated lysine residues [5]. Protein acetylation therefore repre-
sents a cellular regulatory system for controlling protein
function, and disruption of protein acetylation can have signif-
icant impact on cell function. For example, HDAC inhibitors
have a range of eﬀects on cells, including altered gene expres-
sion, growth arrest, diﬀerentiation and cell death [3]. These ef-
fects are attributed to the accumulation of hyper-acetylated
histones and proteins within the cells. HDAC inhibitors are
currently undergoing clinical evaluation for eﬃcacy in the
treatment of human tumors. Disruption of protein acetylation
pathways is therefore a promising target for therapeutic devel-
opment.
In addition to HDAC inhibitors, HAT inhibitors may also
posses therapeutic potential. Several distinct families of HATAbbreviations: HAT, histone acetyltransferase; HDAC, histone deace-
tylase; SER, sensitizer enhancement ratio
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doi:10.1016/j.febslet.2006.06.092proteins have been identiﬁed, including the GCN5/PCAF,
p300/CBP and MYST families [2]. The Tip60 HAT, a MYST
family member, is involved in regulating the cells response to
genotoxic events. Tip60 is activated by ionizing radiation
and regulates the activation of the ATM protein kinase [6],
apoptotic responses [7], the p53 protein [8], and the acetylation
of histones [9,10]. Loss of Tip60 function inhibits the eﬀective
repair of DNA damage [6]. Inhibitors of Tip60 should there-
fore sensitize cells to genotoxic agents such as ionizing radia-
tion. A limited number of HAT inhibitors have been
described. Peptide-CoA conjugates can inhibit puriﬁed PCAF,
but are not cell permeable [11]. Isothiazolone derivatives also
inhibit PCAF, but they exhibit signiﬁcant oﬀ target activity
in vivo due to their high chemical reactivity with thiol groups
[12]. Previous studies demonstrated that anacardic acid inhib-
its the p300 and PCAF HATs in vitro [13], but its in vivo ef-
fects have not been evaluated. Here, we demonstrate that
anacardic acid is an eﬀective inhibitor of HAT activity
in vivo and that it sensitizes cells to ionizing radiation.2. Materials and methods
2.1. Cell culture and irradiation
HeLa and 293T cells were grown in Dulbecco’s modiﬁed Eagle’s
medium/10% fetal calf serum. SQ20B and SCC35 squamous cell carci-
noma cell lines were cultured in modiﬁed eagles medium/10% fetal calf
serum. For cell survival experiments, cells were plated at the appropri-
ate dilution, irradiated, and surviving colonies were stained with crys-
tal violet 10 days later [6]. For anacardic acid (EMD Biosciences, CA)
exposure, cells were preincubated with anacardic acid for 40 min, irra-
diated, then allowed to recover for 4 h. Cells were then switched to
fresh media and allowed to grow for 10 days.
2.2. Western blot and HAT assays
Cells were lyzed in lysis buﬀer (20 mM HEPES, pH 7.4, 150 mM
NaCl, 0.2% Tween 20, 1.5 mM MgCl2, 1 mM EGTA, 2 mM DTT,
50 mM NaF, 500 lM Na3VO4, 1 mM PMSF, 3 lg/ml aprotinin,
3 lg/ml leupeptin). ATM was detected with antibodies 5C2 (Gene-
tex, TX), anti-phosphoserine 1981 (Rockland Biochemicals, PA) or
anti-acetyl lysine antibody (Upstate Biotech, NY). DNA–PKcs anti-
body (clone 25-4), was purchased from Neomarkers, CA and
pS2056 DNA–PKcs antibody was kindly provided by Dr Benjamin
Chen.
HAT assay. Cell extracts were immunoprecipitated with Tip60 anti-
body (Upstate Biotech, NY), washed three times in lysis buﬀer and
twice in HAT assay buﬀer (50 mM Tris, pH 8/10% glycerol/0.1 mM
EDTA/1 mM DTT). Immunoprecipitates were incubated in 60 ll of
HAT assay buﬀer supplemented with acetyl-CoA (100 lM), and bio-
tinylated histone H4 peptide (0.5 lg) for 30 min at 30 C. An aliquot
of the reaction was immobilized onto streptavidin plates, and acetyla-
tion detected using a HAT ELISA as described by us [14].blished by Elsevier B.V. All rights reserved.
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Tip60 is required for many cellular responses to DNA dam-
age, including activation of the ATM protein kinase [6], repair
of DNA-strand breaks [7,9], and both histone acetylation [10]
and chromatin remodeling at sites of DNA damage [15]. To
determine if anacardic acid could inhibit Tip60, Tip60 was
immunoprecipitated from cell extracts and incubated with a
peptide derived from the N-terminus of histone H4, which is
eﬃciently acetylated by Tip60 [6]. Cell extracts immunoprecip-
itated with IgG (Fig. 1A, inset), had minimal HAT activity, as
did extracts immunoprecipitated with Tip60 antibody and then
incubated without substrate peptide. Immunoprecipitations
with Tip60 in the presence of the peptide yielded robust
Tip60 HAT activity. Immunoprecipitated Tip60 was then incu-
bated with the increasing concentrations of anacardic acid andFig. 1. Anacardic acid inhibits Tip60 and blocks activation of ATM
and DNA–PKcs. (A) Inset. HeLa cell extracts were immunoprecipi-
tated (Ab) with IgG or Tip60 antibody. HAT assays were carried out
on washed immunoprecipitates in the absence () or presence (+) of
the substrate peptide derived from the N-terminal of histone H4.
Graph. Immunoprecipitated Tip60 was incubated with either solvent
(DMSO) or anacardic acid for 10 min. Histone H4 substrate peptide
was added, and Tip60 activity expressed as the percent decrease in
activity compared to solvent controls. (B and C). 293T cells were
preincubated in either DMSO () or anacardic acid (30 lM: +) for
30mins. Cells were then treated with bleomycin (5 lM) or ionizing
radiation (IR: 2 Gy) as indicated. Reactions were terminated 40 min
later and cell extracts analyzed by western blot for ATM protein levels,
ATM acetylation (AcLys), ATM autophosphorylation (pS1981),
DNA–PKcs and DNA–PKcs autophosphorylation of serine 2056
(pS2056).the associated HAT activity measured. Anacardic acid inhib-
ited Tip60 with an IC50 of 9 lM (Fig. 1A, graph), with maxi-
mal inhibition above 30 lM. Anacardic acid is therefore an
eﬃcient inhibitor of Tip60 in vitro.
Several previously described HAT inhibitors are not cell per-
meable, and therefore cannot be utilized for cell based studies
[11]. Therefore, we examined the ability of anacardic acid to
inhibit Tip60 functions in vivo. Tip60’s HAT activity is re-
quired for the activation of 2 key regulators of the cells re-
sponse to DNA damage – the ATM and DNA–PKcs protein
kinases [6,14]. Tip60 acetylates ATM, activating ATM’s kinase
activity [6,14], and increasing the autophosphorylation of
ATM on serine 1981. ATM activation can, therefore, be mon-
itored with antibodies which detect the acetylation and auto-
phosphorylation of the ATM protein. In Fig. 1B, cells were
expose to the radiomimetic agent bleomycin, which generates
DNA-strand breaks. ATM was both acetylated and autophos-
phorylated when cells were exposed to bleomycin. Further,
prior treatment with anacardic acid inhibited both the Tip60-
dependent acetylation and activation of the ATM protein
kinase. DNA–PKcs is also activated in a Tip60-depen-
dent manner [14], and this activation can be monitored
through autophosphorylation of serine 2056 [16,17]. Fig. 1C
demonstrates rapid autophosphorylation of serine 2056 of
DNA–PKcs in response to ionizing radiation. Anacardic acid
signiﬁcantly reduced the autophosphorylation of serine 2056,
consistent with previous reports that activation of DNA–PKcs
by DNA damage is partly dependent on the Tip60 HAT [14].
Fig. 1 therefore demonstrates that anacardic acid inhibits both
Tip60 HAT activity in vitro, and Tip60 dependent signaling
pathways in vivo.
The Tip60-dependent activation of ATM is required for cells
to survive exposure to ionizing radiation [6]. This implies that
inhibition of the Tip60-ATM pathway by anacardic acid
should increase cellular sensitivity to ionizing radiation. Ini-
tially, potential cytotoxic eﬀects of anacardic acid treatment
were examined. HeLa cells were exposed to anacardic acid
for 4hr (Fig. 2A), and cell viability examined using a colony
forming assay. Anacardic acid at up to 10 lM did not signiﬁ-
cantly aﬀect cell viability (Fig. 2A: control), although at higher
concentrations there was a small decrease in cell survival. In
Fig. 2B, cells were irradiated in the absence or presence of
increasing concentrations of anacardic acid. In the absence
of anacardic acid, irradiation decreased cell viability to 0.16
(Fig. 2B). When cells were irradiated in the presence of anacar-
dic acid, a signiﬁcant decrease in cell survival was seen, with
maximal radiosensitization between 30 and 100 lM. The
higher concentrations of anacardic acid required to increase
radiosensitivity in vivo (30–100 lM: Fig. 2B) compared to
the inhibition of Tip60 HAT activity in vitro (10–30 lM:
Fig. 1A) presumably reﬂect the uptake and distribution of ana-
cardic acid within the cell. The HAT inhibitor anacardic acid is
therefore an eﬀective radiosensitizer of cells which displays
minimal cytotoxicity. Note that the surviving fractions in
Fig. 2B are corrected for the small decrease in viability caused
by exposure to anacardic acid alone (described in the legend to
Fig. 2B).
To further characterize the ability of anacardic acid to
sensitize cells to ionizing radiation, several tumor cell lines,
including HeLa cells (cervical adenocarcinoma) and 2 rela-
tively radioresistant squamous carcinoma cell lines, SQ20B
and SCC35 [18] were analyzed. HeLa cells exhibited a 3-fold
Fig. 2. Anacardic acid sensitizes HeLa cells to radiation. (A). HeLa cells were incubated in DMSO (0.1%) or anacardic acid for 4 h. The cells were
then switched to fresh media, allowed to grow for 10 days, and surviving cells assessed using a colony formation assay. (B). HeLa cells were incubated
in DMSO (0.1%) or anacardic acid for 30 min and then irradiated (6 Gy). 3.5 h post-irradiation, cells were switched to fresh media, and surviving
cells measured using a colony formation assay. To control for the low levels of toxicity exhibited by anacardic acid at higher concentrations (control),
the surviving fraction of irradiated cells was calculated using the following formula. Surviving fraction = [number of colonies with AA + IR]/[number
of colonies with AA], where AA = anacardic acid, IR = ionizing radiation. Results ± S.D. (n = 4).
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all doses of ionizing radiation tested (Fig. 3A). In contrast,
slightly lower levels of radiosensitization by anacardic acid
were detected in the SQ20B and SCC35 cell lines, with an aver-
age of 2-fold increase in radiosensitivity. The sensitizerFig. 3. Anacardic acid sensitizes tumor cells to the cytotoxic eﬀects of
ionizing radiation. (A) HeLa cells (squares) or (B) SCC35 (circles) or
SQ20B (triangles) cells were incubated with DMSO (0.1%: open
symbols) or anacardic acid (30 lM: ﬁlled symbols) and then irradiated.
4 h later cells were switched to fresh medium, and the surviving
fraction measured 10 days later by colony formation assay.
Results ± S.D. (n = 4).enhancement ration (SER) for each cell line is shown in Table
1. Both HeLa and SQ20B cells showed signiﬁcant sensitization
at both low (2 Gy) and high (6 Gy) doses, whereas SCC35
showed a small eﬀect at 2 Gy (SER = 1.5 ± 0.2) compared to
6 Gy (SER = 8.0 ± 2.0). The radiosensitization observed with
anacardic acid is less than that achieved through genetic inac-
tivation of Tip60 [6]. This diﬀerence may reﬂect the transient
suppression of the ATM/DNA–PKcs DNA repair pathways
by anacardic acid compared to the complete inhibition
achieved by genetic methods. Further, anacardic acid treated
cells retain residual DNA–PKcs and Tip60 activity (Fig. 1),
which may contribute to cell survival. Overall, the HAT inhib-
itor anacardic acid was an eﬀective sensitizer of cells to the
cytotoxic eﬀects of ionizing radiation.4. Discussion
Anacardic acid inhibited the Tip60-dependent acetylation
and activation of the ATM protein kinase in HeLa cells, and
sensitized the cells to the cytotoxic eﬀects of radiation. This
is consistent with the observation that genetic inactivation of
either Tip60 [6] or ATM [19] increases the sensitivity of cells
to DNA damage. Further, the ability of anacardic acid to in-
hibit Tip60 signaling pathways in vivo demonstrates that ana-
cardic acid can cross the cell membrane. This is in contrast to
other HAT inhibitors, including peptide-CoA conjugates [11],
which are not cell permeable. These results therefore demon-
strate the utility of anacardic acid as an in vivo HAT inhibitor.Table 1
SER for anacardic acid
Cell line SER*
2 Gy 6 Gy
HeLa 2.6 ± 0.4 3.0 ± 0.6
SQ20B 2.4 ± 0.2 2.5 ± 0.3
SCC35 1.5 ± 0.2 8.0 ± 2.0
*SER = sensitizer enhancement ratio at 30 lM anacardic acid. Re-
sults ± S.D. (n = 4).
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PCAF and p300 HATs in vitro, with maximal inhibition at
15 lM anacardic acid [13]. Here, we demonstrate that anacar-
dic acid is also an eﬀective inhibitor of the Tip60 HAT in vitro,
with maximal Tip60 inhibition occurring between 10-30 lM
anacardic acid (Fig. 1). PCAF, p300 and Tip60 belong to dis-
tinct HAT sub-families [1,2], with distinct catalytic mecha-
nisms [20]. In addition, anacardic acid has structural
similarities to acetyl-CoA (the acetyl donor for HATs), and
may inhibit binding of acetyl-CoA to the active site of HATs.
Anacardic acid is therefore a relatively non-speciﬁc HAT
inhibitor, with the potential to inhibit multiple HATs. Expo-
sure to anacardic acid is likely to block global cellular HAT
activity, resulting in decreased acetylation of both histones
and other cellular proteins. Since the acetylation of the N-ter-
minal tails of histones is associated with an open chromatin
structure and active gene transcription [4], global inhibition
of cellular HAT activity by anacardic acid will lead to de-
creased histone acetylation, a more compacted chromatin
structure and reduced transcriptional activity. The combina-
tion of these processes may account for the toxicity of anacar-
dic acid seen at higher concentrations.
It has been clearly established that activation of the ATM
protein kinase is required for cells to repair and survive expo-
sure to ionizing radiation [21]. The ability of anacardic acid to
inhibit Tip60 activity and the subsequent activation of ATM
may therefore make a signiﬁcant contribution to the radiosen-
sitizing eﬀects of anacardic. However, given the non-speciﬁc
nature of anacardic acid, including its ability to inhibit PCAF
and p300 [13], a signiﬁcant contribution from altered histone
(or other protein) acetylation patterns to the observed radio-
sensitizing eﬀects of anacardic acid cannot be excluded.
In conclusion, these experiments provide proof of principle
that inhibition of cellular HAT activity can lead to increased
sensitivity to the cytotoxic eﬀects of ionizing radiation. Similar
to the use of HDAC inhibitors, the disruption of the cellular
protein/histone acetylation code by HAT inhibitors can be
exploited to develop new anti-cancer strategies. These results
have important implications for the development of com-
pounds which can enhance the eﬃcacy of radiation therapy
in a clinical setting. Further, HAT inhibitors can be used to
probe the role of global histone and protein acetylation in cel-
lular functions, and provide starting point for the development
of more speciﬁc inhibitors of individual HATs.
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